WG
AXSM icon

Winton Group’s Axsome Therapeutics AXSM Stock Holding History

Winton Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,555
Closed -$997K – 731
2025
Q2 		$997K Buy
+9,555
New +$1.01M 0.05% 437
2024
Q3 		– Sell
-8,823
Closed -$710K – 624
2024
Q2 		$710K Buy
8,823
+5,385
+157% +$399K 0.05% 380
2024
Q1 		$274K Buy
+3,438
New +$289K 0.02% 536
2023
Q3 		– Sell
-5,179
Closed -$372K – 771
2023
Q2 		$372K Sell
5,179
-7,655
-60% -$565K 0.03% 441
2023
Q1 		$792K Buy
12,834
+328
+3% +$21.5K 0.05% 528
2022
Q4 		$965K Sell
12,506
-1,456
-10% -$87K 0.06% 417
2022
Q3 		$623K Sell
13,962
-3,847
-22% -$192K 0.04% 575
2022
Q2 		$682K Buy
17,809
+1,465
+9% +$46.3K 0.04% 611
2022
Q1 		$676K Buy
16,344
+2,335
+17% +$72.4K 0.04% 593
2021
Q4 		$529K Buy
14,009
+4,309
+44% +$159K 0.03% 664
2021
Q3 		$320K Sell
9,700
-3,072
-24% -$120K 0.02% 1064
2021
Q2 		$862K Buy
12,772
+2,111
+20% +$127K 0.05% 608
2021
Q1 		$604K Buy
10,661
+3,901
+58% +$274K 0.03% 773
2020
Q4 		$551K Sell
6,760
-23,082
-77% -$1.73M 0.04% 742
2020
Q3 		$2.13M Buy
29,842
+1,807
+6% +$141K 0.07% 497
2020
Q2 		$2.31M Sell
28,035
-1,254
-4% -$96.5K 0.06% 585
2020
Q1 		$1.72M Sell
29,289
-198,237
-87% -$16.2M 0.05% 623
2019
Q4 		$23.5M Buy
+227,526
New +$9.19M 0.33% 28

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Winton Group's AXSM Position: Q3 2025 in Review

Winton Group sold out of Axsome Therapeutics (AXSM) in Q3 2025, closing a stake of 9,555 shares — an estimated $997K sold.

Winton Group first reported a position in AXSM in Q4 2019 and held it in 18 quarters. The position peaked at $23.5M in Q4 2019. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Winton Group reported no remaining Axsome Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Winton Group sold 9,555 Axsome Therapeutics shares in Q3 2025, an estimated $997K.
  • Winton Group first reported a position in Axsome Therapeutics in Q4 2019 and held it in 18 quarters.
  • Winton Group's Axsome Therapeutics position peaked at $23.5M in Q4 2019.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.